{"id":"https://genegraph.clinicalgenome.org/r/78787cce-6998-47c1-a30f-20e9259c50f9v3.0","type":"EvidenceStrengthAssertion","dc:description":"*TTN* was first reported in association with autosomal dominant hypertrophic cardiomyopathy (HCM) in humans in 2009 (Arimura et al. 2009, PMID 19608031). *TTN* gene encodes titin protein which is a large protein in the sarcomere. There are multiple transcripts with N2BA and N2B as the primary cardiac transcripts. Many variants in *TTN* have been reported in individuals with HCM but the majority are missense without functional data or located in an exon with low percent spliced in (PSI) for cardiac tissue. There is one report of a frameshift located in the A-band (PSI 100%) (Sepp et al. 2022, PMID 35626289), and one termination in the I-band (PSI 100%) (Micheu et al. 2020, PMID 33297573) in individuals with HCM. Also of note, Higashikuse et al. (2019, PMID 31628103) provide strong functional data for two missense variants in the MURF1 binding region.   \n\nCase-control data is contradictory towards an association with HCM. No excess *TTN* variants were noted in cases compared to controls in two studies (Herman et al. 2012, PMID 22335739, Zhang et al. 2017, 28822653). An additional study reported a higher proportion of controls with *TTN* truncations and missense variants compared to cases (Mademont-Soler et al. 2017, PMID: 28771489).\n \nThe gene-disease association is supported by expression studies in the human heart and animal models (Collins et al. 1996, PMID 8841931, Wang et al. 1999, PMID 10093045, Ponten et al. 2008, PMID 18853439, GTEX Consortium 2013, PMID 23715323). Protein interactions and biochemical function studies show Titin interacts with other sarcomere proteins associated with HCM (Freiburg et al. 2009, PMID 8631348, Frazier et al. 2011, PMID 21297871, Satoh et al, 1999, PMID 10462489). Previous mouse models showed homozygous individuals developed signs of HCM (Peng et al. 2007, PMID 17261657, Granzier et al. 2009, PMID 19679835). Most notably, a medaka fish model created through ENU mutagenesis developed features of HCM, and positional cloning led to a *TTN* missense variant in the MURF1 binding region (Higashikuse et al. 2019, PMID 31628103). \n\nThis classification was originally approved by the ClinGen Hypertrophic Cardiomyopathy Gene Curation Expert Panel on December 12, 2016. This gene-disease relationship was re-evaluated on July 27, 2023 by the Hereditary Cardiovascular Disorders GCEP. While more points were initially scored for the gene-disease relationship, the classification was downgraded to Limited due to the contradictory case-control data and limited case-level evidence. As a result of this re-evaluation, the classification did not change.\n\nThis classification pair was last evaluated by the Hereditary Cardiovascular disease GCEP on July 27, 2023. It was reevaluated on October 28, 2025 (SOP v11). Scoring for two cases (PMIDs 28822653, 33297573) carrying truncating variants in *TTN* (TTNtv) was reduced from 0.1 to 0 to reflect the frequency of TTNtv in the population. Additionally, two missense and a TTNtv were added to the curation (PMIDs 39895828, 38880420) but were all scored 0 due to variant type, population frequency or lack of functional evidence of variant impact. The score modifications and additional cases do not change the classification.\n","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/78787cce-6998-47c1-a30f-20e9259c50f9","GCISnapshot":"https://genegraph.clinicalgenome.org/r/c17e22eb-c6fc-487d-bcf6-001bb85fdabd","calculatedEvidenceStrength":"Moderate","changes":[{"id":"cg:sopChange"},{"id":"cg:newEvidence"},{"id":"cg:otherTextChange"},{"id":"cg:summaryChange"}],"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/c17e22eb-c6fc-487d-bcf6-001bb85fdabd_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10104","date":"2025-10-28T16:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/c17e22eb-c6fc-487d-bcf6-001bb85fdabd_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10104","date":"2025-10-30T16:12:24.969Z","role":"Publisher"}],"curationReasonDescription":"While more points were initially scored for the gene-disease relationship, the classification was downgraded to Limited due to the contradictory case-control data and limited case-level evidence. ","curationReasons":["RecurationTiming"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c17e22eb-c6fc-487d-bcf6-001bb85fdabd_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/49a309de-01cf-4adb-a432-f29201e823ef","type":"EvidenceLine","dc:description":"unclear if pt had other variants in MYH7 or MYBPC3, PSI 83% (below threshold of 90%)","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/49a309de-01cf-4adb-a432-f29201e823ef_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23396983","allele":{"id":"https://genegraph.clinicalgenome.org/r/576ed1e9-a88e-466d-809b-e2216fa3b368","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001267550.2(TTN):c.31763-1G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA139366"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/c97d0c07-0564-4176-8337-8fe0c7b74cbd","type":"EvidenceLine","dc:description":"Truncation variants in TTN (TTNtv) are common in the population - no functional evidence for variant impact - gnomAD v4.1 Popmax 0.000000849 (European non Finnish)","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c97d0c07-0564-4176-8337-8fe0c7b74cbd_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/38880420","allele":{"id":"https://genegraph.clinicalgenome.org/r/f9dea022-7a3d-41f3-a7dd-508d5bcf63cb","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001267550.2(TTN):c.11312-4027del","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2580616630"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/d3e12145-05f1-4641-bfec-67489ae9e249","type":"EvidenceLine","dc:description":"Non-essential splice site variant\n","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d3e12145-05f1-4641-bfec-67489ae9e249_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23396983","allele":{"id":"https://genegraph.clinicalgenome.org/r/1f28a8e7-cfae-4680-9892-ebf9fc1a3ee6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001267550.2(TTN):c.97193-3T>C","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA1986598"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/0bfd7279-9b4c-469a-855e-2db1c84e2ba7","type":"EvidenceLine","dc:description":"Missense variants are common in TTN. Located in the I band (PSI 3%)","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0bfd7279-9b4c-469a-855e-2db1c84e2ba7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33012304","allele":{"id":"https://genegraph.clinicalgenome.org/r/23f407b9-adf3-4cf6-9d02-fa0ec4ddfaa0","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001267550.2(TTN):c.48053C>T (p.Ala16018Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA349612248"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/f7808f38-8af2-48c0-b131-8bb7ed5642c0","type":"EvidenceLine","dc:description":"Benign missense mutations in TTN are common, no evidence for pathogenic role - not scored.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f7808f38-8af2-48c0-b131-8bb7ed5642c0_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25979592","allele":{"id":"https://genegraph.clinicalgenome.org/r/4a5edc4b-73f6-483b-95ad-94b72169ffef","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001267550.2(TTN):c.29220C>G (p.Asn9740Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA501191"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/d0429e18-e817-4d7c-9e1c-741f28798663","type":"EvidenceLine","dc:description":"missense variants in TTN are common, ANKRD1 is not definitively established to be associated with HCM","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d0429e18-e817-4d7c-9e1c-741f28798663_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19608031","allele":{"id":"https://genegraph.clinicalgenome.org/r/d67cd2cc-7e2f-4b7c-a5b2-8dc394143b1d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001267550.2(TTN):c.29543G>A (p.Arg9848Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA1999362"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/d0429e18-e817-4d7c-9e1c-741f28798663_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"mutations increased binding of titin/connectin to CARP","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/c17e22eb-c6fc-487d-bcf6-001bb85fdabd_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ce23e90c-3d45-4640-92d0-16a22880320b_family_segregation","type":"FamilyCosegregation","dc:description":"Not enough segregations and confounding variables","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28223422","rdfs:label":"Family 1","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/ce23e90c-3d45-4640-92d0-16a22880320b","type":"Family","rdfs:label":"Family 1","ethnicity":{"id":"cg:NotHispanicOrLatino"}},"meetsInclusionCriteria":false,"phenotypePositiveAllelePositive":3},{"id":"https://genegraph.clinicalgenome.org/r/ca038732-4e5f-460e-a085-3f23aef7e8e0_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19608031","rdfs:label":"CM1480","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/ca038732-4e5f-460e-a085-3f23aef7e8e0","type":"Family","rdfs:label":"CM1480","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/b872202b-3bcc-48fd-b970-7052011e03eb","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19608031","rdfs:label":"II-4","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":43,"allele":{"id":"https://genegraph.clinicalgenome.org/r/d67cd2cc-7e2f-4b7c-a5b2-8dc394143b1d"},"ethnicity":{"id":"cg:NotHispanicOrLatino"},"previousTesting":true,"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/d0429e18-e817-4d7c-9e1c-741f28798663_variant_evidence_item"}}},"meetsInclusionCriteria":false,"phenotypePositiveAllelePositive":2,"proband":{"id":"https://genegraph.clinicalgenome.org/r/b872202b-3bcc-48fd-b970-7052011e03eb"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/e64f8faa-842a-4857-8615-821a59955dbc","type":"EvidenceLine","dc:description":"Missense variants in TTN are common ","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e64f8faa-842a-4857-8615-821a59955dbc_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28797094","allele":{"id":"https://genegraph.clinicalgenome.org/r/82ac7b82-aaed-49eb-924f-7cd73939dac9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001267550.2(TTN):c.65182C>G (p.Leu21728Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA310310"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/0f2bc4c9-57e3-4dc7-8288-05d4507b7429","type":"EvidenceLine","dc:description":"Intronic variant in meta-transcript","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0f2bc4c9-57e3-4dc7-8288-05d4507b7429_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23396983","allele":{"id":"https://genegraph.clinicalgenome.org/r/859761e0-eff7-4236-b2ff-2d6e76bb3cfd","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001267550.2(TTN):c.11312-4158C>T","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA238168"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/1b98c7df-f92b-4150-99e5-507a69a5fe07","type":"EvidenceLine","dc:description":"inframe insertions at this loci are common in ExAC","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1b98c7df-f92b-4150-99e5-507a69a5fe07_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23396983","allele":{"id":"https://genegraph.clinicalgenome.org/r/42d62418-6a7c-42bd-8eac-f18fd80a3d23","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001267550.2(TTN):c.33513_33514insATA (p.Glu11171_Glu11172insIle)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2580611008"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/65e58d89-e269-442e-b114-4b1f9011d5c3","type":"EvidenceLine","dc:description":"missense variants are not known to be disease-causing for cardiomyopathy, pt also has LAMA4 variant, PKP2 variant, and TTN insertion (p.Tyr10856insLys)","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/65e58d89-e269-442e-b114-4b1f9011d5c3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25979592","allele":{"id":"https://genegraph.clinicalgenome.org/r/ca54272f-c838-4865-bc15-691355b932bf","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001267550.2(TTN):c.67147G>A (p.Gly22383Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA140455"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/452f637b-7fc8-4b0d-bbd5-53cf05715fee","type":"EvidenceLine","dc:description":"While this variant is in the I-band (PSI 100%), truncations are common in the general population for TTN (see case control data). Without any functional data we were not able to score","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/452f637b-7fc8-4b0d-bbd5-53cf05715fee_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33297573","allele":{"id":"https://genegraph.clinicalgenome.org/r/d60d3519-0dbf-48c5-9d4c-2530a3051b80","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001267550.2(TTN):c.15070G>T (p.Glu5024Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA349595448"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/c5644db2-af1e-4b01-a5bc-85406040441e","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c5644db2-af1e-4b01-a5bc-85406040441e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31628103","allele":{"id":"https://genegraph.clinicalgenome.org/r/4be487a3-0475-4a1f-989d-0713343ce8a2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001267550.2(TTN):c.100684G>A (p.Asp33562Asn)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA349424979"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/c5644db2-af1e-4b01-a5bc-85406040441e_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Increased binding to MURF1. Fish model showed a TTN missense variant in the same region lead to HCM phenotype","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/664e421d-4e3e-4b38-89f3-79982fbc4d85","type":"EvidenceLine","dc:description":"patient also carries a pathogenic MYBPC3 variant (c.1483C>G, p.R495G). The TTN variant is located in the I-band (PSI 20%)","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/664e421d-4e3e-4b38-89f3-79982fbc4d85_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33012304","allele":{"id":"https://genegraph.clinicalgenome.org/r/dee28bcd-8e70-4ee4-b231-4a6f7c809912","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001267550.2(TTN):c.34612+1G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA1998034"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/c17e22eb-c6fc-487d-bcf6-001bb85fdabd_cc_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ec55d45a-803e-46ce-8ae1-ec267cc07b02","type":"EvidenceLine","dc:description":"No excess in cases over controls.","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ec55d45a-803e-46ce-8ae1-ec267cc07b02_cc_evidence_item","type":"Finding","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22335739","rdfs:label":"HCM Case-Control","caseCohort":{"id":"https://genegraph.clinicalgenome.org/r/4292a64b-6ed6-4be6-8032-57341a2025f8","type":"Cohort","allGenotypedSequenced":231,"alleleFrequency":0.01298701298701299,"detectionMethod":"Next-generation or dideoxy sequencing. Only looked at truncating mutations.","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ec55d45a-803e-46ce-8ae1-ec267cc07b02_cc_evidence_item"}],"numWithVariant":3,"relatedCondition":{"id":"obo:MONDO_0005045"}},"controlCohort":{"id":"https://genegraph.clinicalgenome.org/r/0eaf1798-ee09-4c1f-ba75-93e9e6ec211f","type":"Cohort","allGenotypedSequenced":249,"alleleFrequency":0.02811244979919679,"detectionMethod":"Next-generation or dideoxy sequencing. Only looked at truncating mutations.","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ec55d45a-803e-46ce-8ae1-ec267cc07b02_cc_evidence_item"}],"numWithVariant":7},"method":{"id":"cg:AggregateVariantAnalysis"},"statisticalSignificanceType":""}],"specifiedBy":"GeneValidityCaseControlAggregateVariantAnalysisCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/9af55760-1c37-4be3-b50f-7dc36e92f901","type":"EvidenceLine","dc:description":"No excess in cases over controls. 7/13 TTN+ve cases also carried a sarcomere gene variant.","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9af55760-1c37-4be3-b50f-7dc36e92f901_cc_evidence_item","type":"Finding","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28822653","rdfs:label":"HCM Case-Control","caseCohort":{"id":"https://genegraph.clinicalgenome.org/r/93cd4293-c3de-4d02-9bbc-be81869b32d1","type":"Cohort","allGenotypedSequenced":529,"alleleFrequency":0.02457466918714556,"detectionMethod":"Next-generation sequencing of N2B and Novex-3 transcripts. Only looked at truncating mutations.","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9af55760-1c37-4be3-b50f-7dc36e92f901_cc_evidence_item"}],"numWithVariant":13,"relatedCondition":{"id":"obo:MONDO_0005045"}},"controlCohort":{"id":"https://genegraph.clinicalgenome.org/r/48310197-de35-483f-a4b1-4b1108cf529f","type":"Cohort","allGenotypedSequenced":307,"alleleFrequency":0.0260586319218241,"detectionMethod":"Next-generation sequencing of N2B and Novex-3 transcripts. Only looked at truncating mutations.","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9af55760-1c37-4be3-b50f-7dc36e92f901_cc_evidence_item"}],"numWithVariant":8},"method":{"id":"cg:AggregateVariantAnalysis"},"statisticalSignificanceType":""}],"specifiedBy":"GeneValidityCaseControlAggregateVariantAnalysisCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/ba90cf78-0c69-4ea2-ae5c-fc2c097d65fe","type":"EvidenceLine","dc:description":"Truncating variants were not seen with any frequency in the HCM cohort. Missense variants were seen in both cohorts. Missense variants in TTN have not been shown to cause cardiomyopathy. ","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ba90cf78-0c69-4ea2-ae5c-fc2c097d65fe_cc_evidence_item","type":"Finding","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28771489","rdfs:label":"HCM vs controls without structural heart disease","caseCohort":{"id":"https://genegraph.clinicalgenome.org/r/8e383b5a-b989-48bb-bc24-ee028a014b93","type":"Cohort","allGenotypedSequenced":303,"alleleFrequency":0,"detectionMethod":"25 gene cardiomyopathy panel ","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ba90cf78-0c69-4ea2-ae5c-fc2c097d65fe_cc_evidence_item"}],"numWithVariant":0,"relatedCondition":{"id":"obo:MONDO_0005045"}},"controlCohort":{"id":"https://genegraph.clinicalgenome.org/r/1b9b7237-62ee-4d6a-85cd-87018e9652f3","type":"Cohort","allGenotypedSequenced":427,"alleleFrequency":0.00702576112412178,"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ba90cf78-0c69-4ea2-ae5c-fc2c097d65fe_cc_evidence_item"}],"numWithVariant":3},"method":{"id":"cg:AggregateVariantAnalysis"},"statisticalSignificanceType":""}],"specifiedBy":"GeneValidityCaseControlAggregateVariantAnalysisCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/ad8fc34f-e48a-46d1-aeb1-cb1c196bee5f","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ad8fc34f-e48a-46d1-aeb1-cb1c196bee5f_cc_evidence_item","type":"Finding","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28797094","rdfs:label":"Deep intronic TTN variants","caseCohort":{"id":"https://genegraph.clinicalgenome.org/r/9d434343-e1bf-4041-85d2-60b98521076b","type":"Cohort","allGenotypedSequenced":16,"alleleFrequency":0.0625,"detectionMethod":"Whole gene sequencing 26 genes","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ad8fc34f-e48a-46d1-aeb1-cb1c196bee5f_cc_evidence_item"}],"numWithVariant":1,"relatedCondition":{"id":"obo:MONDO_0005045"}},"controlCohort":{"id":"https://genegraph.clinicalgenome.org/r/80daac91-1a62-47d0-8250-66c47dbadde9","type":"Cohort","allGenotypedSequenced":152026,"alleleFrequency":0.00001315564442924237,"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ad8fc34f-e48a-46d1-aeb1-cb1c196bee5f_cc_evidence_item"}],"numWithVariant":2},"method":{"id":"cg:SingleVariantAnalysis"},"statisticalSignificanceType":""}],"specifiedBy":"GeneValidityCaseControlSingleVariantAnalysisCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallCaseControlEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/dac3b335-d380-44f2-bbf0-143ffd56e1c6","type":"EvidenceLine","dc:description":"absent from gnomAD v4.1 - located in the A band in a PSI 100% exon however no functional evidence for the variant ","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dac3b335-d380-44f2-bbf0-143ffd56e1c6_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/38880420","allele":{"id":"https://genegraph.clinicalgenome.org/r/fe21d130-2582-410d-a5c2-85f7b78680d5","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001267550.2(TTN):c.90736T>C (p.Trp30246Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA349507012"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/d1fd42b2-36c0-4f81-8834-9d16d181099d","type":"EvidenceLine","dc:description":"high population frequency (0.4% in NFE)","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d1fd42b2-36c0-4f81-8834-9d16d181099d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23396983","allele":{"id":"https://genegraph.clinicalgenome.org/r/9173a5c9-a7b6-4f9c-b0c6-ba6cdfb2fc0d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001267550.2(TTN):c.69716-5C>G","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA295531"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/2f12df4f-a473-412b-b38d-36b5e7606b58","type":"EvidenceLine","dc:description":"Patient also has a MYH7 variant, ACTN2 variant, and three TTN missense variants","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2f12df4f-a473-412b-b38d-36b5e7606b58_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28323875","allele":{"id":"https://genegraph.clinicalgenome.org/r/2e5eceb2-454e-44da-a35e-0323469f7af9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001267550.2(TTN):c.12704C>A (p.Ser4235Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA349610806"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/5f9f8224-53c9-4fa4-a74f-a4d048de2aeb","type":"EvidenceLine","dc:description":"nonessential splice site variant ","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5f9f8224-53c9-4fa4-a74f-a4d048de2aeb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23396983","allele":{"id":"https://genegraph.clinicalgenome.org/r/d320d530-5783-4c78-a488-00c0b8f1f359","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001267550.2(TTN):c.10115-4G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2004166"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/f274e90e-a5a3-4639-ae54-37f519d75726","type":"EvidenceLine","dc:description":"Benign missense mutations in TTN are common, no evidence for pathogenic role - not scored. Common in general population","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f274e90e-a5a3-4639-ae54-37f519d75726_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25979592","allele":{"id":"https://genegraph.clinicalgenome.org/r/c241e452-044b-4e7b-a9e3-fd34469bc157","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001267550.2(TTN):c.45408G>T (p.Lys15136Asn)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA289089"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/f274e90e-a5a3-4639-ae54-37f519d75726_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"gnomAD MAF of 0.007696 in the European (non-finnish) pop is greater than the MAF cutoff for the GCEP. ","functionalDataSupport":"No"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/a9e09dfb-95eb-465a-ac66-151c862a6221","type":"EvidenceLine","dc:description":"nonessential splice site variant","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a9e09dfb-95eb-465a-ac66-151c862a6221_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23396983","allele":{"id":"https://genegraph.clinicalgenome.org/r/e27288b2-c93b-4c6b-bff2-946e0fd4028f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001267550.2(TTN):c.1398+4C>T","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA179423"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/4d287809-9b74-44cf-8ef2-b91a21e9ddb8","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4d287809-9b74-44cf-8ef2-b91a21e9ddb8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31628103","allele":{"id":"https://genegraph.clinicalgenome.org/r/338890ee-605c-4daf-99cb-7db1735f5dc5","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001267550.2(TTN):c.98260T>G (p.Ser32754Ala)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA349433122"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/4d287809-9b74-44cf-8ef2-b91a21e9ddb8_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Increased the binding of MURF1 to titin (Fig. 6A,C,E). Fish model of a TTN mutation in the same region led to HCM phenotype. ","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/893c0042-818b-4730-956d-2063e633d2a2","type":"EvidenceLine","dc:description":"Insertions have no evidence of pathogenicity for cardiomyopathy, co-occurence with other variants. ","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/893c0042-818b-4730-956d-2063e633d2a2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25979592","allele":{"id":"https://genegraph.clinicalgenome.org/r/51495e4c-4c05-4feb-b2cf-2ef9e434dac3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001267550.2(TTN):c.33516_33517insAAG (p.Glu11172_Tyr11173insLys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA915942273"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/0bb28b2c-e8f7-47dc-8441-d3f60e79d905","type":"EvidenceLine","dc:description":"gnomAD v4.1 Grpmax FAF 0.00051897 (east Asian) - located in the I band - PSI 48% - no functional - population frequency is too high, low expression and no functional evidence which is required to score variants in TTN for HCM","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0bb28b2c-e8f7-47dc-8441-d3f60e79d905_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/39895828","allele":{"id":"https://genegraph.clinicalgenome.org/r/10df988c-ef91-4a7f-a5b9-51a0a0f9e9b0","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001267550.2(TTN):c.23965C>T (p.Arg7989Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA181876"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/7c816e60-1f4a-49af-9698-f2f1beffda64","type":"EvidenceLine","dc:description":"Not a known mechanism for disease for HCM and TTNtv are common in the population","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7c816e60-1f4a-49af-9698-f2f1beffda64_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35626289","allele":{"id":"https://genegraph.clinicalgenome.org/r/f82396b7-8667-4024-8c15-5e70ae661f19","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001267550.2(TTN):c.70437del (p.Lys23480AsnfsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2573134320"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/803fa13b-76a5-41c0-8803-871c6a0b39e1","type":"EvidenceLine","dc:description":"No functional data to support pathogenicity. Missense variants are very common in TTN. Patient also carries a homozygous MYL2 variant.  ","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/803fa13b-76a5-41c0-8803-871c6a0b39e1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33012304","allele":{"id":"https://genegraph.clinicalgenome.org/r/1450d907-ebd5-4ae3-a684-81b9f304a47a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001267550.2(TTN):c.103484T>C (p.Leu34495Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA1985596"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/2f554e0a-a2ab-4d27-a734-9bb07e58d1de","type":"EvidenceLine","dc:description":"Benign missense mutations in TTN are common, no evidence for pathogenic role - not scored. gnomAD MAF of 0.00006152 in the african american pop. ","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2f554e0a-a2ab-4d27-a734-9bb07e58d1de_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25979592","allele":{"id":"https://genegraph.clinicalgenome.org/r/24dad630-5c7c-43be-865a-a8732f983fa8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001267550.2(TTN):c.6910G>A (p.Val2304Met)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA349681446"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/fc23c20f-0d87-4d7f-9c1d-98450bb12ef7","type":"EvidenceLine","dc:description":"missense variants in TTN are common, ANKRD1 is not definitively established to be associated with HCM","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fc23c20f-0d87-4d7f-9c1d-98450bb12ef7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19608031","allele":{"id":"https://genegraph.clinicalgenome.org/r/e53126f1-7160-4aea-a52b-0a5c0327940e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001267550.2(TTN):c.29231G>A (p.Arg9744His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA309560"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/fc23c20f-0d87-4d7f-9c1d-98450bb12ef7_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Shown to increase binding of TTN N2A with CARP.\n\n","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/9ca5989f-0dfe-424e-b7f6-8b0babe40dab","type":"EvidenceLine","dc:description":"Non-constitutive exon PSI 80% (threshold normally 90/95%). No evidence for pathogenicity. Unclear if this splice variant co-occurs with MYBPC3 or MYH7 mutation.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9ca5989f-0dfe-424e-b7f6-8b0babe40dab_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23396983","allele":{"id":"https://genegraph.clinicalgenome.org/r/fe02ebf5-0e5e-4a72-8119-652af08338c6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001267550.2(TTN):c.29042-2A>C","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA309191"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/1b217640-bf3f-429d-a67b-75107e02e4f8","type":"EvidenceLine","dc:description":"inframe insertions at this loci are common in ExAC\n","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1b217640-bf3f-429d-a67b-75107e02e4f8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23396983","allele":{"id":"https://genegraph.clinicalgenome.org/r/42d62418-6a7c-42bd-8eac-f18fd80a3d23"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/c17e22eb-c6fc-487d-bcf6-001bb85fdabd_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c17e22eb-c6fc-487d-bcf6-001bb85fdabd_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e96bfa38-49c9-4126-b32b-8a10f9ae9372","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/82571fed-933b-44d7-bd35-6c7f9db903f3","type":"Finding","dc:description":"https://www.proteinatlas.org/ENSG00000155657-TTN/tissue/primary+data","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18853439","rdfs:label":"HPA expression","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/bfbb9045-bd7c-4cee-9374-afc18d055bde","type":"EvidenceLine","dc:description":"FHL2 has not been implicated in HCM ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e52a6f2c-8f4e-4074-a8b5-f62ea3297966","type":"Finding","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16465475","rdfs:label":"TTN p.Arg740Leu increased binding to FHL2","demonstrates":{"id":"obo:MI_0935"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/b746f652-777b-4a4b-a087-ec3ca75d146c","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e8ff083c-cde4-40f1-91bb-9f513eaca637","type":"Finding","dc:description":"Titin is a componant of the sarcomere, as are known HCM genes - shared biochemical function.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21297871","rdfs:label":"Sarcomere Component","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/0a266382-13e5-45ef-8240-22db9da04d17","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f993b186-3097-4974-b23c-a8b58cb1c2c8","type":"Finding","dc:description":"Cardiomyocytes from hypertrophic cardiomyopathy (HCM) patients showed higher Fpassive compared to control hearts and significantly lower Fpassive after PKD treatment. In addition, we found higher phosphorylation at CaMKII-dependent titin sites in HCM compared to control hearts. Expression and phosphorylation of HSP27, a substrate of PKD, were elevated in HCM hearts, which was associated with increased PKD expression and phosphorylation. The relocalization of HSP27 in HCM away from the sarcomeric Z-disk and I-band suggested that HSP27 failed to exert its protective action on titin extensibility. This protection could, however, be restored by administration of HSP27, which significantly reduced Fpassive in HCM cardiomyocytes.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32351396","rdfs:label":"HCM Cell Expression","demonstrates":{"id":"cg:GeneExpressionB"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/9cbda3d1-931f-48e0-b545-483507d54fde","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/53cb4e24-923d-4717-9aa6-bb6c87eb8faf","type":"Finding","dc:description":"TTN is highly expressed in heart muscle in GTex","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23715323","rdfs:label":"GTEx","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/b1c5731d-3c86-4453-907e-637e63cc74a8","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/806665de-64ad-4320-8aeb-f098abb7b6e8","type":"Finding","dc:description":"Titin expression was present in controls (measured by PCR)\nTitin was upregulated in Guinea Pigs with hypertrophy due to band constriction ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8841931","rdfs:label":"Expression in Guinea Pigs ","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/a610d5cb-50ad-4d46-89a2-ef6f288124d2","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7583265a-46c0-4008-aed7-3a0416a46c74","type":"Finding","dc:description":"Titin directly interacts with MYBPC3","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8631348","rdfs:label":"MYBPC3 interaction","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/4b757122-a4e4-406e-9207-ac710045c6a9","type":"EvidenceLine","dc:description":"TCAP association with HCM is \"disputed.\" (Last curated in 2022.)","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/07f4dde8-daba-4b27-9029-85c4bbc8a206","type":"Finding","dc:description":"Mutations in TCAP in HCM patients alter binding to TTN","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15582318","rdfs:label":"TCAP interaction","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/7507575a-7651-40c4-b4cc-132dcc073cbb","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e52221f8-d9df-4033-b165-efefb707f218","type":"Finding","dc:description":"Western blot shows TTN expression in both cases and controls ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10093045","rdfs:label":"Guinea Pigs II","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/c17e22eb-c6fc-487d-bcf6-001bb85fdabd_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/31f5de97-0367-4bfb-98dc-efef35e7c747","type":"EvidenceLine","dc:description":"CARP (ANKRD1) is disputed in association with HCM\n","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8fed588d-3376-44bd-a596-5169af570145","type":"FunctionalAlteration","dc:description":"2 TTN mutations significantly increase TTN binding to CARP","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19608031","rdfs:label":"CARP binding"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/fa742658-6c73-41cd-8eaa-c24177be873b","type":"EvidenceLine","dc:description":"initial report","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9ad010fe-c9db-4890-a7f5-0590779a5a0d","type":"FunctionalAlteration","dc:description":"TTN missense (Arg740Leu) increased the binding affinity of titin to alpha-actitin in a yeast two-hybrid assay","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10462489","rdfs:label":"binding to alpha-actitin"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/c17e22eb-c6fc-487d-bcf6-001bb85fdabd_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f3452724-2600-463d-811c-4c4329e863d9","type":"EvidenceLine","dc:description":"Homozygous change and a related phenotype that is not clearly recapitulating human HCM - 2 points reduced to 0.5","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/12ba3bbd-f27e-4965-a14e-91acc02cae68","type":"Finding","dc:description":"Reduced contractile response to beta-adrengergic agonists and extracellular calcium and reduced rate of calcium uptake in M-line deficient mice. Also reduced levels of calmodulin, phospholamban and SERCA1. Ca2+ sensitivity unchanged. Mice develop cardiac hypertrophy and heart failure.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17261657","rdfs:label":"Mouse Model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/074fb3e7-bf14-47ae-8e5b-0287e69b5cea","type":"EvidenceLine","dc:description":"Homozygous change and a related phenotype that is not clearly recapitulating human HCM - 2 points reduced to 0.5","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5c46bbb7-a6fc-4c54-91dd-376aa3c12394","type":"Finding","dc:description":"Adult mice missing exons 219-225 or N2B TTN develop diastolic dysfunction and hypertrophied hearts with upregulation of FHL proteins.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19679835","rdfs:label":"Mouse model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/32d29d98-1bef-49c2-873c-e225160517f1","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3a4f33b3-0e12-49e6-aef3-661f0c7a540a","type":"Finding","dc:description":"left ventricular hypertrophy and diastolic dysfunction are consistent with HCM. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31628103","rdfs:label":"Medaka Fish","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":3}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":5.5}],"evidenceStrength":"Limited","sequence":12149,"specifiedBy":"GeneValidityCriteria11","strengthScore":6.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/--UvDONaFm4","type":"GeneValidityProposition","disease":"obo:MONDO_0005045","gene":"hgnc:12403","modeOfInheritance":"obo:HP_0000006"},"version":"3.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_c17e22eb-c6fc-487d-bcf6-001bb85fdabd-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}